Literature DB >> 27789332

Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies.

Pankaj Dwivedi1, Kenneth D Greis2.   

Abstract

Granulocyte colony-stimulating factor is a hematopoietic cytokine that stimulates neutrophil production and hematopoietic stem cell mobilization by initiating the dimerization of homodimeric granulocyte colony-stimulating factor receptor. Different mutations of CSF3R have been linked to a unique spectrum of myeloid disorders and related malignancies. Myeloid disorders caused by the CSF3R mutations include severe congenital neutropenia, chronic neutrophilic leukemia, and atypical chronic myeloid leukemia. In this review, we provide an analysis of granulocyte colony-stimulating factor receptor, various mutations, and their roles in the severe congenital neutropenia, chronic neutrophilic leukemia, and malignant transformation, as well as the clinical implications and some perspective on approaches that could expand our knowledge with respect to the normal signaling mechanisms and those associated with mutations in the receptor.
Copyright © 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789332      PMCID: PMC5241233          DOI: 10.1016/j.exphem.2016.10.008

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  81 in total

1.  A direct role for Met endocytosis in tumorigenesis.

Authors:  Carine Joffre; Rachel Barrow; Ludovic Ménard; Véronique Calleja; Ian R Hart; Stéphanie Kermorgant
Journal:  Nat Cell Biol       Date:  2011-06-05       Impact factor: 28.824

2.  Impaired neutrophil maturation in truncated murine G-CSF receptor-transgenic mice.

Authors:  Tetsuo Mitsui; Sumiko Watanabe; Yoshihiro Taniguchi; Sachiyo Hanada; Yasuhiro Ebihara; Takeshi Sato; Toshio Heike; Masao Mitsuyama; Tatsutoshi Nakahata; Kohichiro Tsuji
Journal:  Blood       Date:  2003-04-15       Impact factor: 22.113

3.  Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome.

Authors:  Norihiro Awaya; Hideo Uchida; Yoshitaka Miyakawa; Kentaro Kinjo; Hiromichi Matsushita; Hideaki Nakajima; Yasuo Ikeda; Masahiro Kizaki
Journal:  J Cell Physiol       Date:  2002-06       Impact factor: 6.384

4.  Activation mechanisms of STAT5 by oncogenic Flt3-ITD.

Authors:  Chunaram Choudhary; Christian Brandts; Joachim Schwable; Lara Tickenbrock; Bülent Sargin; Andrea Ueker; Frank-D Böhmer; Wolfgang E Berdel; Carsten Müller-Tidow; Hubert Serve
Journal:  Blood       Date:  2007-03-13       Impact factor: 22.113

5.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

6.  Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

Authors:  Jean Donadieu; Thierry Leblanc; Brigitte Bader Meunier; Mohamed Barkaoui; Odile Fenneteau; Yves Bertrand; Micheline Maier-Redelsperger; Marguerite Micheau; Jean Louis Stephan; Noel Phillipe; Pierre Bordigoni; Annie Babin-Boilletot; Philippe Bensaid; Anne Marie Manel; Etienne Vilmer; Isabelle Thuret; Stephane Blanche; Eliane Gluckman; Alain Fischer; Françoise Mechinaud; Bertrand Joly; Thierry Lamy; Olivier Hermine; Bruno Cassinat; Christine Bellanné-Chantelot; Christine Chomienne
Journal:  Haematologica       Date:  2005-01       Impact factor: 9.941

7.  Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.

Authors:  F Dong; R K Brynes; N Tidow; K Welte; B Löwenberg; I P Touw
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

8.  Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases.

Authors:  S J Corey; A L Burkhardt; J B Bolen; R L Geahlen; L S Tkatch; D J Tweardy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

9.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy.

Authors:  Philip S Rosenberg; Blanche P Alter; Audrey A Bolyard; Mary Ann Bonilla; Laurence A Boxer; Bonnie Cham; Carol Fier; Melvin Freedman; George Kannourakis; Sally Kinsey; Beate Schwinzer; Connie Zeidler; Karl Welte; David C Dale
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

10.  Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

Authors:  M L McLemore; J Poursine-Laurent; D C Link
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

View more
  47 in total

1.  Candida albicans Elicits Pro-Inflammatory Differential Gene Expression in Intestinal Peyer's Patches.

Authors:  Navjot Singh; Heather C Kim; Renjie Song; Jaskiran K Dhinsa; Steven R Torres; Magdia De Jesus
Journal:  Mycopathologia       Date:  2019-06-22       Impact factor: 2.574

2.  Integrative analysis identifies DNMTs against immune-infiltrating neutrophils and dendritic cells in colorectal cancer.

Authors:  Qili Shi; Libing Shen; Jun Gan; Lirong He; Jing Lin; Shiyu Guo; Zi Xiong; Jie Lin; Shun Zhang
Journal:  Epigenetics       Date:  2019-03-16       Impact factor: 4.528

3.  An integrative sparse boosting analysis of cancer genomic commonality and difference.

Authors:  Yifan Sun; Zhengyang Sun; Yu Jiang; Yang Li; Shuangge Ma
Journal:  Stat Methods Med Res       Date:  2019-07-07       Impact factor: 3.021

4.  SWATH-Proteomics of Ibrutinib's Action in Myeloid Leukemia Initiating Mutated G-CSFR Signaling.

Authors:  Pankaj Dwivedi; Somchai Chutipongtanate; David E Muench; Mohammad Azam; Harry Leighton Grimes; Kenneth D Greis
Journal:  Proteomics Clin Appl       Date:  2020-05-25       Impact factor: 3.494

5.  Molecular mechanisms of aberrant neutrophil differentiation in glycogen storage disease type Ib.

Authors:  Sang Wan Sim; Yuyeon Jang; Tae Sub Park; Byung-Chul Park; Young Mok Lee; Hyun Sik Jun
Journal:  Cell Mol Life Sci       Date:  2022-04-18       Impact factor: 9.261

6.  Prognostic impact of CSF3R mutations in favorable risk childhood acute myeloid leukemia.

Authors:  Katherine Tarlock; Todd Alonzo; Yi-Cheng Wang; Robert B Gerbing; Rhonda E Ries; Tiffany Hylkema; Jenny L Smith; Julia E Maxson; Soheil Meshinchi
Journal:  Blood       Date:  2020-04-30       Impact factor: 22.113

Review 7.  The membrane protein KCNQ1 potassium ion channel: Functional diversity and current structural insights.

Authors:  Gunjan Dixit; Carole Dabney-Smith; Gary A Lorigan
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-12-09       Impact factor: 3.747

8.  Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia.

Authors:  Theodore P Braun; Cody Coblentz; Brittany M Curtiss; Daniel J Coleman; Zachary Schonrock; Sarah A Carratt; Rowan L Callahan; Breanna Maniaci; Brian J Druker; Julia E Maxson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-29       Impact factor: 11.205

9.  Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia.

Authors:  Yongbin Meng; Hetong Zhao; Zhihao Zhao; Zifei Yin; Zhe Chen; Juan Du
Journal:  Cell Biochem Biophys       Date:  2021-06-12       Impact factor: 2.194

10.  Heterozygous germ line CSF3R variants as risk alleles for development of hematologic malignancies.

Authors:  Amy M Trottier; Lawrence J Druhan; Ira L Kraft; Amanda Lance; Simone Feurstein; Maria Helgeson; Jeremy P Segal; Soma Das; Belinda R Avalos; Lucy A Godley
Journal:  Blood Adv       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.